OMERS Administration Corp’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

OMERS Administration Corp’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-34,998	Closed	-$353K	–	358
2022 Q4	$353K	Hold	34,998	–	–	0.01%	166
2022 Q3	$347K	Hold	34,998	–	–	0.01%	174
2022 Q2	$342K	Hold	34,998	–	–	﹤0.01%	182
2022 Q1	$342K	Hold	34,998	–	–	﹤0.01%	187
2021 Q4	$339K	Hold	34,998	–	–	﹤0.01%	162
2021 Q3	$340K	Hold	34,998	–	–	﹤0.01%	207
2021 Q2	$338K	Buy	+34,998	New	+$344K	﹤0.01%	262

OMERS Administration Corp's EBAC Position: Q1 2023 in Review

OMERS Administration Corp sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 34,998 shares — an estimated $353K sold.

OMERS Administration Corp first reported a position in EBAC in Q2 2021 and held it in 7 quarters. The position peaked at $353K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

OMERS Administration Corp reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
OMERS Administration Corp sold 34,998 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $353K.
OMERS Administration Corp first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
OMERS Administration Corp's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $353K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on OMERS Administration Corp's 13F filing for Q1 2023, filed 12 May 2023.